Anterogen.Co.,Ltd. (KOSDAQ:065660)
30,550
-1,100 (-3.48%)
May 20, 2026, 3:30 PM KST
Anterogen.Co.,Ltd. Market Cap
Anterogen.Co.,Ltd. has a market cap or net worth of 305.69 billion as of May 20, 2026. Its market cap has increased by 46.52% in one year.
Market Cap
305.69B
Enterprise Value
262.10B
Revenue
7.54B
Ranking
n/a
PE Ratio
n/a
Stock Price
30,550.00
Market Cap Chart
Since February 15, 2016, Anterogen.Co.,Ltd.'s market cap has increased from 291.82B to 305.69B, an increase of 4.75%. That is a compound annual growth rate of 0.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 305.69B | -34.79% |
| Dec 30, 2025 | 468.79B | 155.02% |
| Dec 30, 2024 | 183.83B | 10.53% |
| Dec 28, 2023 | 166.31B | 16.26% |
| Dec 29, 2022 | 143.05B | -76.39% |
| Dec 30, 2021 | 605.82B | 6.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Proteina | 488.45B |
| SillaJen | 428.82B |
| Genomictree | 350.34B |
| Helixmith | 341.21B |
| GC Cell | 326.84B |
| BINEX | 324.21B |
| HLB Therapeutics | 286.02B |
| NeoImmuneTech | 247.66B |